Dr Reddy sets Q2 results date: what it means for Dr Reddy stock
Published on 10/08/2026 at 12:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Dr. Reddy's Laboratories will announce its second-quarter and six-month results on October 23, 2026, after a board meeting, according to StockTitan. The disclosure also schedules an earnings call at 10:00 a.m. ET on the same date, covering the quarter and six months ended September 30, 2026.
October 23 sets the next checkpoint
The scheduled release gives the market a defined date for testing whether the company's recent operating volatility has eased. The next report will cover the period from April through September 2026, while management is expected to discuss performance across its generics, active pharmaceutical ingredients and services, innovative medicines, and consumer health businesses.
The event is more than a calendar marker because the prior quarter combined substantial revenue with weaker cash generation. The June 2026 quarter produced INR 80.71 billion of revenue and INR 4.44 billion of net income, according to the standardized financial statement for Dr. Reddy's Laboratories.
Q1 revenue reached INR 81.0 billion
StockFin reported that revenue in the first quarter of fiscal 2027 grew 7.3 percent from the prior quarter to INR 81.0 billion. Operating profit was INR 3.23 billion, producing a 4.0 percent operating margin.
That comparison puts the coming release under a demanding operational lens. Operating profit had been INR 13.67 billion at a 15.6 percent margin in the December 2025 quarter, before turning negative at INR 1.75 billion in the March 2026 quarter, according to the same quarterly analysis. The figures show why revenue growth alone will not settle the stock's next debate; margin recovery and cash conversion are equally important.
Results date frames the next move
Dr. Reddy's Laboratories has therefore set October 23, 2026 as the next major information point for shareholders. The combination of a 7.3 percent sequential revenue increase and a 4.0 percent operating margin gives the upcoming report two clear benchmarks: maintaining commercial growth and rebuilding profitability.
Dr. Reddy's Laboratories at a glance
- Company: Dr. Reddy's Laboratories Limited
- Ticker: DRREDDY
- Primary exchange: National Stock Exchange of India
- Sector / Industry: Healthcare / Pharmaceuticals
- Index membership: NIFTY 50
- Next earnings date: October 23, 2026
